John Y L Chung

Years Active: 2017-2021
Publications (10 Years): 3

Merck Research Rahway

University of California Irvine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Merck Research Rahway

United States

Principal Scientist :: Process Research and Development

AbbVie Inc

United States

Senior Scientist :: Medicinal Chemistry

University of Wisconsin Madison

United States

Post-Doc :: Chemistry

Education History

University of California Irvine Jun 01 1980 - Jun 30 1984

United States

PHD :: Chemistry

Publications

Artis Klapars, John Y L Chung, John Limanto, Ralph Calabria, Louis-Charles Campeau, Kevin R Campos, Wenyong Chen, Stephen M Dalby, Tyler A Davis, Daniel A DiRocco, Alan M Hyde, Amude M Kassim, Mona Utne Larsen, Guiquan Liu, Peter E Maligres, Aaron Moment, Feng Peng, Rebecca T Ruck, Michael Shevlin, Bryon L Simmons, Zhiguo Jake Song, Lushi Tan, Timothy J Wright, Susan L Zultanski
Efficient synthesis of antiviral agent uprifosbuvir enabled by new synthetic methods. Chemical science 12 (26) (2021)
John Y L Chung, Dongfang Meng, Michael Shevlin, Venugopal Gudipati, Qinghao Chen, Yizhou Liu, Colin Yu-Hong Lam, Aaron Dumas, Jeremy Scott, Qiang Tu, Feng Xu
Diastereoselective FeCl3·6H2O/NaBH4 Reduction of Oxime Ether for the Synthesis of β-Lactamase Inhibitor Relebactam. The Journal of organic chemistry 85 (2) (2020)
Feng Peng, Yonggang Chen, Cheng-Yi Chen, Peter G Dormer, Amude Kassim, Mark McLaughlin, Robert A Reamer, Edward C Sherer, Zhiguo J Song, Lushi Tan, Matthew T Tudge, Baoqiang Wan, John Y L Chung
Asymmetric Formal Synthesis of the Long-Acting DPP-4 Inhibitor Omarigliptin. The Journal of organic chemistry 82 (17) (2017)

John Y L Chung.css-eqlu8i{font-size:small;padding-left:4px;}